Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Beclometasone Dipropionate Suspension for Inhalation

Approval Number

国药准字H20253765

Company江西艾施特制药有限公司

Registration Date

April 1, 2025

Drug Information

Generic Name

吸入用丙酸倍氯米松混悬液

Dosage Form

吸入制剂

Strength

2ml：0.8mg

Drug Type

化学药品

Registration Date

April 1, 2025

Company Information

Applicant Company

Company Name江西艾施特制药有限公司

Company Address

江西省南昌市南昌高新技术产业开发区瑶湖北大道3333号济民可信总部及新药产业化基地项目（一期）质检楼1层

Manufacturing Company

Company Name江西艾施特制药有限公司

Company Address

江西省南昌市南昌高新技术产业开发区瑶湖北大道3333号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

吸入用丙酸倍氯米松混悬液 - NMPA 批准文号 | MedPath